Advances in Protein-Based Nanoparticles for Pulmonary Drug Delivery

Strategic Insights -

Researchers from Amity University in Uttar Pradesh, India, have made significant strides in the development of protein-based nanoparticles for pulmonary drug delivery. These nanoparticles possess unique properties, such as biocompatibility, biodegradability, high drug loading capacity, and tunable release profiles, making them ideal for targeted delivery and stimulus-responsive drug release. Despite the potential benefits, immunogenicity, protein stability, scale-up production, and regulatory approval remain significant challenges to their clinical translation.

Key Takeaways:

  • Protein-based nanoparticles (PNPs) have been found to possess several distinct advantages, including superior biocompatibility, biodegradability, high drug loading capacity, and tunable release profiles.
  • PNPs can be coated with ligands and polymers for receptor-mediated targeting and increased penetration of the mucus, rendering them well-suited to circumvent biological barriers in the lung.
  • Formulation strategies, such as spray drying, freeze drying, and electrospray membrane, have been optimized to improve the aerodynamics and stability of PNPs for inhalation.
  • Multifunctional PNPs have been developed, enabling targeted delivery and stimulus-responsive drug release, but further research is needed to overcome challenges such as immunogenicity and regulatory approval.
  • The research has been peer-reviewed and published in the Journal of Nanoparticle Research, highlighting the potential of PNPs for pulmonary drug delivery.

Statistics:

  • 2025: The year in which the research was published.
  • 27(7): The volume and issue number of the Journal of Nanoparticle Research where the research was published.
  • 2025: The date of publication of the news report by NewsRx LLC.
  • 2501: The page number of the news report by NewsRx LLC.

Sources:

  • NewsRx. Recent Findings in Nanoparticles Described by Researchers from Amity University (Protein Based Nanoparticles for Pulmonary Drug Delivery: Advances, Challenges, and Future Perspectives). Respiratory Therapeutics Week. July 14, 2025; p 2501.
  • Journal of Nanoparticle Research, 2025;27(7).
  • Springer. Journal of Nanoparticle Research. www.springer.com.
  • Springer. Journal of Nanoparticle Research. www.springerlink.com/content/1388-0764/